
- Accepting New Patients
- Telehealth Visits
- Insurance plan information

Karen Zhang, MD
Family Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information



Karen Zhang, MD
Family Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Family Medicine, American Board of Family Medicine
Degree
- MD, University of Texas Medical Branch at Galveston
My expertise
Specialties
- Family Medicine
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224061%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224061%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 54 reviews
- January 17, 20265 out of 5 Stars
Dr. Zhang is the best. Listens, knows all questions and routines to test (competent and thorough), friendly as could be. Followed up labs she ordered to call and say all negative for stroke. Who does that anymore?! Privilege to meet her.
- January 13, 20265 out of 5 Stars
Nice job very happy
- January 6, 20265 out of 5 Stars
Excellent staff thank you for your service
- January 5, 20265 out of 5 Stars
Karen Zhang was incredibly punctual, helpful, and provided me with all the answers I had questions to! I would 100% visit this urgent care again if I had to and recommend her as well.
- January 1, 20265 out of 5 Stars
Dr. Zhang was excellent and built trust with my teenager right away. She treated him and his questions with respect. Loved working with her.
- December 31, 20255 out of 5 Stars
Dr. Zhang was fantastic. She listened well, showed much concern, and was very patient.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.